Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health.
We have more than 20 years of experience providing a range of contract research, development and manufacturing services across the drug development continuum, with a focus on early-stage discovery and development of new molecular entities (NMEs). Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.
At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.
Freedom to make a difference.
Aragen employees, at all levels, are empowered to make decisions. They are encouraged to take responsibility, raise issues, reward team members, drive changes, and own outcomes. This results in a highly committed and responsive workforce focused on exceeding customer expectation.
One Team. One Purpose.
We believe in the power of teams over individuals, especially when uniting around our goal to keep our customers ahead in the race for better health. At Aragen, we don’t stand on formality and protocol. Instead, we function as agile, cross-functional teams focused on addressing customer problems and accelerating solutions. We work collaboratively to deliver on our promise ‘Together Ahead’.
Say what you do. Do what you say.
At Aragen, we are mindful of our role in the global biopharma ecosystem and fully aware of our responsibility in providing reliable, consistent and quality data to accelerate the programs of our customers. What we do impacts lives through better health outcomes.
Unlocking our collective genius.
Innovation at Aragen is about developing solutions that are more effective and commercially relevant. Some of the best scientific talent makes this possible. As an extension of our customers’ in-house R&D, we continuously look for new and better ways to cultivate novel approaches to drug discovery, development and manufacturing.
Exceed expectation consistently.
We keep customer needs at the center of all our decisions. By providing flexible, integrated, end-to-end services along the concept-to-commercial continuum, we give our customers effective and timely solutions. A collaborative and transparent approach to every engagement demonstrates our commitment to partnership. Our customer repeat rate of over 90% is a reflection of our relentless focus on customer centricity.
First and Always.
‘Safety and Compliance Always’ is a way of life at Aragen. As a solutions partner to the life sciences industry, every Aragen employee recognizes its importance and impact within the organization and on external stakeholders. Regular reviews, training, seminars, and implementation of technologies, demonstrate our commitment to embedding and continuously improving company-wide safety and compliance.
We have established strong proprietary project management capabilities, referred to as “XLRATE”, that helps us effectively execute and manage our large and growing client base. XLRATE comprises of four key pillars:
We have a dedicated Project Management team which gets introduced for each project right at the time of initiation and owns the project until its successful delivery to the client. The team leverages various organizational strengths in supply chain, IT, talent management and quality systems to ensure a high-quality, seamless and timely project delivery. Effective project management has helped us maintain on-time successful project delivery, even during the COVID-19 pandemic, which has been well recognized by our clients. Further, our project management teams also maintain consistent communication flow with our clients, through regular e-mails and weekly updates. We believe our project management capability is a key differentiator, and enables us to maintain an agile and flexible organization. This in turn leads to better asset utilization through the efficient planning of resources.
Over the last 20 years, we have invested in high-quality and advanced infrastructure across our facilities in India and the United States. We currently operate six facilities, of which five are in India and one is in the west coast of the US. Co-location of R&D laboratories and manufacturing facilities ensures a seamless technology transfer from feasibility to commercial supply.
| S. No | Location | Area(1)(sq. ft.) | Land (acres) | Type of Campus | Certifications/ Accreditations |
|---|---|---|---|---|---|
| 1. | Nacharam, Telangana, India | 183,670 | 15.9 | Discovery R&D | AAALAC(2) |
| 264,056 | Manufacturing | USFDA, EDQM, PMDA, WHO, CDSCO, ISO | |||
| 2. | Mallapur, Telangana, India | 360,108 | 15.8 | Discovery R&D, Formulations Pilot plant | CDSCO, USFDA, NABL for analytical |
| 3. | Bengaluru, Karnataka, India | 190,000 | 8 | Discovery R&D | AAALAC(3) |
| 4. | Pune, Maharashtra, India | 50,773 | 5.0 | Discovery GLP Safety Assessment | GLP, AAALAC(3) |
| 5. | Visakhapatnam, Andhra Pradesh, India(4) | 220,950 | 10.3 | Manufacturing | MFDS, DCA, CDSCO, ISO, WHO |
| 6. | Morgan Hill, California, USA(5) | 48,663 | 3.5 | Discovery Biologics R&D | AAALAC(2) |
Notes:
(1)Includes area of existing buildings.
(2)The AAALAC accreditation has been obtained for our biology animal unit located in Nacharam, Telangana and Morgan Hill, California
(3) AAALAC accredited
(4)Facility situated on a Special Economic Zone and held on leasehold basis
(5)Facility held on leasehold basis
Our research facilities and systems are certified with ISO 9001:2015, ISO 14001:2015, ISO 45001: 2018 and ISO 50001: 2018 standards. Further, our analytical laboratory located at Mallapur (Hyderabad) in India is USFDA approved and is spread over 10,000 sq. ft. in area. This facility is compliant with 21 CFR Part 11 systems maintained under cGMP conditions.
